The Human Epidermal Growth Factor Related (HER) receptor family comprises at least four cognate receptor tyrosine kinases (RTKs, namely HER1, HER2, HER3, and HER4) which - as a functional unit - drive breast cancer disease and have prognostic and predictive impact [1]. This evidence concerns the gene EGFR and breast carcinoma.